Download PDF

Other users also viewed these articles

Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study Eugenio de Miguel; Cristina Fernández-Carballido; Jordi Gratacós; José L. Pablos; Xavier Juanola; Rafael Ariza; Pau Terradas-Montana; Cristina Sanabra; Carlos Sastré;
Reumatol Clin. 2023;19:99-105
Recommendations of the Mexican College of Rheumatology for the management of spondyloarthritis Greta Reyes-Cordero; Favio Enríquez-Sosa; Citlallyc Gomez-Ruiz; Verónica Gonzalez-Diaz; José Dionisio Castillo-Ortiz; Sergio Duran-Barragán; J. Santos Duran-Ortiz; Rolando Espinosa-Morales; Jorge I. Gamez-Nava; Laura Gonzalez-Lopez; Bernardo Julian-Martínez; Angélica Mendoza-Fuentes; Cesar Ramos-Remus; Cesar Pacheco-Tena; Ruben Burgos-Vargas;
Reumatol Clin. 2021;17:37-45
Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;
Reumatol Clin. 2024;20:123-7